Intravitreal Aflibercept for Patients with Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Retrospective Trial
Purpose: This study aimed to investigate whether intravitreal aflibercept was safe and effective in patients with acute nonarteritic anterior ischemic optic neuropathy (NAION). Methods: This was a chart study of 25 individuals with acute NAION (25 eyes). An intravitreal injection of 2 mg/0.05 mL of...
Main Authors: | Kai-Chun Cheng, Chien-Chih Chiu, Kuo-Jen Chen, Yo-Chen Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/14/4868 |
Similar Items
-
Efficacy and safety of transdermal electrical stimulation in patients with nonarteritic anterior ischemic optic neuropathy
by: Gen Miura, et al.
Published: (2023-10-01) -
The Effect of Intravitreal Injection of Erythropoietin in Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy
by: Alireza Dehghani, et al.
Published: (2017-04-01) -
Visual outcome of various dose of glucocorticoids treatment in nonarteritic anterior ischemic optic neuropathy– a retrospective analysis
by: Fang-Fang Zhao, et al.
Published: (2024-03-01) -
Approaches to Potentiated Neuroprotective Treatment in the Rodent Model of Ischemic Optic Neuropathy
by: Zara Mehrabian, et al.
Published: (2021-06-01) -
Synergistic Protection of Retinal Ganglion Cells (RGCs) by SARM1 Inactivation with CNTF in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy
by: Yan Guo, et al.
Published: (2024-01-01)